Sequential Brands Group Announces Fourth Quarter and Full Year 2017 Financial Results
Feb 28, 2018 13:02 pm UTC| Business
Q4 2017 Revenue increased 3% to $46.9 million Full Year 2017 Revenue increased 8% to $167.5 million NEW YORK, Feb. 28, 2018 -- Sequential Brands Group, Inc. (“Sequential” or the “Company”) (Nasdaq:SQBG) today...
JLT Acquires a Leading Trade Credit and Political Risk Broker in the US
Feb 28, 2018 13:01 pm UTC| Business
JLT further strengthens its US Specialty business with key acquisition NEW YORK, Feb. 28, 2018 -- Jardine Lloyd Thompson Group plc (JLT), one of the world's leading providers of insurance, reinsurance, and employee...
Folding IBCs Market is expected to grow at a CAGR of 4.8% during 2017 -2027
Feb 28, 2018 13:01 pm UTC| Business
VALLEY COTTAGE, NY, Feb. 28, 2018 -- Flexible intermediate bulk container (IBC) is a reusable industrial container designed for the transport and storage of bulk liquid and granulated substances, such as chemicals, food...
Feb 28, 2018 13:01 pm UTC| Business
CHICAGO, Feb. 28, 2018 -- Enablon, a Wolters Kluwer business, and TapRooT®, each world leaders in EHS Operations, announce a partnership today that will enable their customers to be even more efficient in preventing...
Feb 28, 2018 13:01 pm UTC| Business
SAN JOSE, Calif., Feb. 28, 2018 -- Pulse Secure, the leader in secure access solutions for people, devices, things and services, today announced a cyber security industry first by achieving Common Criteria certification...
iAnthus Signs Leases for High-Traffic Dispensary Locations in Brooklyn and Tampa
Feb 28, 2018 13:01 pm UTC| Business
NEW YORK, Feb. 28, 2018 -- iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”), (CSE:IAN) (OTCQB:ITHUF), which owns, operates, and partners with licensed cannabis operations throughout the United States, is...
Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
Feb 28, 2018 13:01 pm UTC| Business
SAN DIEGO, Feb. 28, 2018 -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that Mark J. Gergen,...